: Sun Pharma has recalled certain lots of Nimodine capsules, a drug indicated to treat brain haemorrhage, in the U.S. market due to crystal formation.

As per the information available on the U.S. Food and Drug Administration website, the company is recalling the Nimodine capsules, 30 mg due to ‘crystallisation’. The recall falls under Class II category, and it is done in a situation in which the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.